We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.53B
AUM Growth
-$1.13M
(-0.07%)
Cap. Flow
+$46.2M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
1,502
New
414
Increased
344
Reduced
260
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEWR
New Relic, Inc.
NEWR
|
+$10.5M |
| 2 |
Alibaba
BABA
|
+$10.4M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$10.3M |
| 4 |
DQ
Daqo New Energy
DQ
|
+$8.18M |
| 5 |
KE Holdings
BEKE
|
+$8.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Green Brick Partners
GRBK
|
+$48.6M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$38.6M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$35.9M |
| 4 |
JD.com
JD
|
+$13.5M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Healthcare | 10.56% |
| 3 | Consumer Discretionary | 9.55% |
| 4 | Industrials | 7.76% |
| 5 | Energy | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Bioceres Crop Solutions
BIOX
$22.8M
| $237K | 0.02% |
20,968
-3,663
| -15% | -$43.9K |
|
802
PPG Industries
PPG
$25.7B
| $236K | 0.02% |
1,821
-561
| -24% | -$78.8K |
|
803
Stellantis
STLA
$21B
| $236K | 0.02% |
+12,352
| New | +$231K |
|
804
Biohaven
BHVN
$2.19B
| $236K | 0.02% |
9,067
-1,000
| -10% | -$20.8K |
|
805
Cincinnati Financial
CINF
$26.7B
| $236K | 0.02% |
+2,303
| New | +$241K |
|
|
RCM
806
DELISTED
R1 RCM Inc. Common Stock
RCM
| $235K | 0.02% |
15,600
+1,640
| +12% | +$27.6K |
|
807
Sphere Entertainment
SPHR
$5.84B
| $235K | 0.02% |
+6,316
| New | +$233K |
|
|
OSG
808
DELISTED
Overseas Shipholding Group Inc.
OSG
| $234K | 0.02% |
53,300
+34,435
| +183% | +$143K |
|
809
Vital Farms
VITL
$483M
| $234K | 0.02% |
20,195
+8,766
| +77% | +$101K |
|
810
Protolabs
PRLB
$2.14B
| $234K | 0.02% |
8,846
+1,742
| +25% | +$52.6K |
|
811
Lamb Weston
LW
$7.12B
| $233K | 0.02% |
+2,523
| New | +$256K |
|
812
CRH
CRH
$66.9B
| $233K | 0.02% |
+4,262
| New | +$242K |
|
813
Bank of America
BAC
$447B
| $232K | 0.02% |
8,480
-8,020
| -49% | -$237K |
|
814
DoorDash
DASH
$90.9B
| $232K | 0.02% |
+2,917
| New | +$237K |
|
|
LKFT
815
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
| $231K | 0.02% |
6,680
+45
| +0.7% | +$1.75K |
|
816
Morgan Stanley
MS
$338B
| $231K | 0.02% |
+2,825
| New | +$245K |
|
|
SILK
817
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $230K | 0.02% |
+15,371
| New | +$320K |
|
818
Victory Capital Holdings
VCTR
$6.85B
| $230K | 0.02% |
6,910
+497
| +8% | +$16.6K |
|
819
CALL
Visa
V
$675B
| $230K | 0.02% |
1,000
| – | – |
|
|
820
PUT
Visa
V
$675B
| $230K | 0.02% |
1,000
| – | – |
|
821
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $230K | 0.02% |
+3,146
| New | +$251K |
|
822
CONMED
CNMD
$1.48B
| $230K | 0.02% |
+2,276
| New | +$262K |
|
823
ProFrac Holding
ACDC
$929M
| $229K | 0.01% |
+21,076
| New | +$244K |
|
|
SFBS
824
ServisFirst Bancshares
SFBS
$4.84B
| $229K | 0.01% |
+4,381
| New | +$232K |
|
825
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.09B
| $228K | 0.01% |
5,640
-2,080
| -27% | -$85.3K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Prelude Capital Management held 1,502 positions worth $1.53B, down 0.07% from $1.54B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Prelude Capital Management deployed $46.2M of net new capital in Q3 2023, opening 414 new positions and adding to 344 existing holdings. Its largest new stake was New Relic, Inc.: 130,823 shares worth $11.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $38.6M trimmed.
- Prelude Capital Management's largest Q3 2023 buy was New Relic, Inc.: 130,823 shares worth $11.2M.
- Prelude Capital Management added most to Alibaba in Q3 2023, an estimated $10.4M increase.
- Prelude Capital Management's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $38.6M.
- Prelude Capital Management fully exited Green Brick Partners in Q3 2023, selling an estimated $48.6M.
- Prelude Capital Management's ten largest holdings make up 22% of its $1.53B portfolio in Q3 2023.
- Prelude Capital Management opened 414 new positions and closed 396 in Q3 2023.
- Prelude Capital Management's portfolio value fell 0.07% quarter-over-quarter to $1.53B.
Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.